![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0028.jpg)
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 3, May/June 2019
156
AFRICA
10. Park MK.
Pediatric Cardiology for Practitioners.
St Louis: Mosby, 2002.
11. Eerola A, Jokinen E, Boldt T, Pihkala J. The influence of percutaneous
closure of patent ductus arteriosus on left ventricular size and function:
a prospective study using two- and three-dimensional echocardiography
and measurements of serum natriuretic peptides.
J Am Coll Cardiol
2006;
47
(5): 1060–1066. DOI: 10.1016/j.jacc.2005.09.067.
12. Davis GK, Bamforth F, Sarpal A, Dicke F, Rabi Y, Lyon ME. B-type
natriuretic peptide in pediatrics.
Clin Biochem
2006;
39
(6): 600–605.
DOI: 10.1016/j.clinbiochem.2005.12.004.
13. Li N, Wang J. Brain natriuretic peptide and optimal management of
heart failure
. J Zhejiang Univ Sci B
2005;
6
(9): 877–884. DOI:10.1631/
jzus.2005.B0877.
14. Mahfouz RA, Alzaiat A, Gad M. Association of aortic stiffness to
brain natriuretic peptide in children before and after device closure of
patent ductus arteriosus.
J Saudi Heart Assoc
2015;
27
(1): 23–30. DOI:
10.1016/j.jsha.2014.06.001.
15. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren
D. Clinical signs of heart failure are associated with increased levels
of natriuretic peptide types B and A in children with congenital heart
defects or cardiomyopathy.
Acta Paediatr
2004;
93
(3): 340–345. DOI:
10.1111/j.1651-2227.2004.tb02958.x.
16. Mir TS, Falkenberg J, Friedrich B, Gottschalk U, Le TP, Laer S,
et al.
Levels of brain natriuretic peptide in children with right ventricular
overload due to congenital cardiac disease.
Cardiol Young
2005;
15
(4):
396–401. DOI:10.1017/s1047951105000831.
17. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K,
et al
. Pulmonary hypertension after operations for congenital heart
disease: analysis of risk factors and management.
J Thorac Cardiovasc
Surg
1996;
112
(6): 1600–1607; discussion 1607–1609. DOI: 10.1016/
s0022-5223(96)70019-3.
18. Blount S, Vogel J. Pulmonary hypertension. In: Moss A, Adams F, eds.
Heart Disease in Infants, Children, and Adolescents
. Baltimore: Williams
and Wilkins, 1968: 947.
19. Bader H. Importance of the gerontology of elastic arteries in the
development of essential hypertension
. Clin Physiol Biochem
1983;
1
(1):
36–56. PMID: 6679476.
…continued from page 150
Applications and supporting documents should be submitted to
World Heart Federation; ‘CSIA Proposals’, 32 rue de Malatrex,
1201 Geneva, Switzerland. e-mail
kate.ralston@worldheart.orgIf you have any queries, please contact Chip Bollman at
cbolman46@gmail.commore information on CSIA, visit
www.CSIAforRHD.org